HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes

Nature

Volumn 391, Issue 6665, 1998, Pages 397-401

  Collins, Kathleen L ^a,b,c   Chen, Benjamin K ^e   Kalams, Spyros A ^c,d   Walker, Bruce D ^c,d   Baltimore, David ^a,f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e ROCKEFELLER UNIVERSITY   (United States)

^f CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

ALKALINE PHOSPHATASE; CELL DEATH; CELLS, CULTURED; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, NEF; HIV-1; HLA-A2 ANTIGEN; HUMANS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032556872     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/34929     Document Type: Article

References (27)

1. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. Endocylosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med. 2, 338-342 (1996).
2. O'Brien, M. C. & Bolton, W. E. Comparison of cell viability probes compatible with fixation and permeabilization for combined surface and intracellular staining in flow cytometry. Cytometry 19, 243-255 (1995).
3. Philpott, N. J. et al. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 97, 2244-2251 (1996).
4. Walter, J. et al. Stimulation of human cytotoxic T cells with HIV-1-derived peptides presented by recombinant HLA-A2 peptide complexes. Int. Immunol. 9, 451-459 (1997).
5. Johnson, R. et al. HIV-1 gag specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immmol. 147, 1512-1521 (1991).
6. Walker, B. et al. Long term culture and fine specificity of human cytotoxic T lymphocyte clones reactive with human immunodeficiency virus type I. Proc. Natl Acad. Sci. USA 86, 9514-9518 (1989).
7. Tsomides, T. et al. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180, 1283-1293 (1994).
8. Yang, O. et al. Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J. Viral. 70, 5799-5806 (1996).
9. Pelletier, J. & Sonenberg, N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334, 320-325 (1988).
10. Ghattas, I., Sanes, J. & Majors, J. The encephalomycocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol. Cell Biol. 11, 5848-5859 (1991).
11. Chen, B., Gandhi, R. & Baltimore, D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70, 6044-6053 (1996).
12. Xu, X. et al. Evasion of CTL responses by Nef-dependent induction of fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186, 1-10 (1997).
13. Philips, R. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T-cell recognition. Nature 354, 453-459 (1991).
14. Borrow, P. et al. Antiviral pressure exerted by HIV-1 -specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med. 3, 205-211 (1997).
15. Goulder, P. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med. 3, 212-217 (1997).
16. Kerkau, T., Schmitt-Landgraf, R., Schimpl, A. & Wecker, E. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res. Hum. Retrovir. 5, 613-620 (1989).
17. + T cell line, CEM-E5, after HIV-1 infection. J. Immunol. 143, 2858-2866 (1989).
18. Howcroft, T., Strebel, K., Martin, M. & Singer, D. Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260, 1320-1322 (1993).
19. Kerkau, T. et al. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class 1 molecules. J. Exp. Med. 185, 1295-1305 (1997).
20. Hill, A. et al. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell unes against which they were raised. J. Exp.Med. 181, 2221-2228 (1995).
21. Jondal, M., Schirmbeck, R. & Reimann, J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302 (1996).
22. O'Brien, T. R. et al. Serum HIV-1 RNA levels and time to develop of AIDS in the multicenter hemophila cohort study. J. Am. Chem. Assoc. 276, 105-110 (1996).
23. Mellors, J. W. et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 72, 1167-1170 (1996).
24. Pantaleo, G. et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl Acad. Sci. USA 94, 254-258 (1997).
25. Adachi, A. et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291 (1986).
26. Ausubel, F. et al. Current Protocols in Molecular Biology 1-9.11.1-9.11.18 (Wiley, New York, 1996).
27. + T cells binds very tightly to the restricting class 1 major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl Acad. Sci. USA 88, 11276-11280 (1991).